Revelation Biosciences (REVB) Stock Price, Quote, News & History

Revelation Biosciences Inc (REVB) Stock Price, Quote, News & History

REVBNASDAQ

Trade with Public

$1.15

0.021.77%

Last update: Apr 8, 9:30 AM

Key Statistics

Open

$1.15

Volume / Avg.

1.64K / 654.75K

Day Range

$1.15 - $1.15

52 Wk Range

1.06 - 44.77

Market Cap

$6.81M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.52%

Days to Cover

Recent Revelation Biosciences Inc News

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus (UPDATED)

US stock futures slightly down after 2 days of gains. Trump withdraws tariffs on EU, while Q3 GDP exceeds estimates.

Vishaal Sanjay

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours?

Revelation Biosciences shares jumped after the FDA agreed that a single Phase 2/3 study could support an application for its acute kidney injury treatment.

Mohd Haider

Why Revelation Biosciences (REVB) Stock Is Down 38%

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.27M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

12.47M

Free Cash Flow (TTM)

-8.27M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

4.20M

Valuation Metrics

Enterprise Value

-$5.82M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.47

Earnings Yield % (TTM)

-2157.66%

Earnings Yield % (FWD)

-374.32%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.38

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.70M

Debt to Equity

0.08

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.15

Volume / Avg.

1.64K / 654.75K

Day Range

$1.15 - $1.15

52 Wk Range

1.06 - 44.77

Market Cap

$6.81M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.52%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Revelation Biosciences (REVB) stock?

You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.

View our list of the best stock brokerages

Who are Revelation Biosciences (REVB) competitors?

Other companies in Revelation Biosciences’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Immuron Ltd (NASDAQ:IMRN), Can Fite Biopharma Ltd (AMEX:CANF), BioRestorative Therapies Inc (NASDAQ:BRTX) and AlphaTON Capital Corp (NASDAQ:ATON).

What is the forecast, or price target, for Revelation Biosciences (REVB) stock?

There is no analysis for Revelation Biosciences to provide a consensus price target.

What is the current price for Revelation Biosciences (REVB)?

The stock price for Revelation Biosciences (NASDAQ: REVB) is $1.15 last updated April 8, 2026 at 9:30 AM EDT.

Does Revelation Biosciences (REVB) pay a dividend?

There are no upcoming dividends for Revelation Biosciences.

When is Revelation Biosciences (NASDAQ:REVB) reporting earnings?

Revelation Biosciences does not have any upcoming earnings scheduled.

Is Revelation Biosciences (REVB) going to split?

There is no upcoming split for Revelation Biosciences.

What sector and industry does Revelation Biosciences (REVB) operate in?

Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ernexa Therapeutics Inc

Can Fite Biopharma Ltd

BioRestorative Therapies Inc

NASDAQ:BRTX

$0.26

3.11%

AlphaTON Capital Corp

NASDAQ:ATON

$0.31

0.03%

AIxCrypto Holdings Inc

NASDAQ:AIXC

$1.36

9.68%

TransCode Therapeutics Inc

Alaunos Therapeutics Inc

Key Statistics

Open

$1.15

Volume / Avg.

1.64K / 654.75K

Day Range

$1.15 - $1.15

52 Wk Range

1.06 - 44.77

Market Cap

$6.81M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.52%

Days to Cover

Recent Revelation Biosciences Inc News

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus (UPDATED)

US stock futures slightly down after 2 days of gains. Trump withdraws tariffs on EU, while Q3 GDP exceeds estimates.

Vishaal Sanjay

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours?

Revelation Biosciences shares jumped after the FDA agreed that a single Phase 2/3 study could support an application for its acute kidney injury treatment.

Mohd Haider

Why Revelation Biosciences (REVB) Stock Is Down 38%

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.27M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

12.47M

Free Cash Flow (TTM)

-8.27M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

4.20M

Valuation Metrics

Enterprise Value

-$5.82M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.47

Earnings Yield % (TTM)

-2157.66%

Earnings Yield % (FWD)

-374.32%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$2.38

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.70M

Debt to Equity

0.08

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.15

Volume / Avg.

1.64K / 654.75K

Day Range

$1.15 - $1.15

52 Wk Range

1.06 - 44.77

Market Cap

$6.81M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.52%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry